Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel TMS Target for Anxiety: a Confirmatory Randomized Clinical Trial

NCT06376877 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06376877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06376877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel TMS Target for Anxiety: a Confirmatory Randomized Clinical Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 1, 2024
Completion date
February 1, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, mental disorder, psychiatric disorder